Quick Answer
PROCEPT BioRobotics Corp reported R&D Expense of $71.28 million for fiscal year 2025.
PROCEPT BioRobotics Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $71.28M | +14.4% |
| 2024 | $62.30M | +28.6% |
| 2023 | $48.45M | +67.2% |
| 2022 | $28.98M | +52.6% |
| 2021 | $18.99M | +16.7% |
| 2020 | $16.27M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.19M | +9.3% | +3.1% |
| June 30, 2025 | $17.63M | +0.7% | +7.5% |
| March 31, 2025 | $16.40M | +25.4% | -1.5% |
| September 30, 2024 | $16.65M | +43.5% | -4.9% |
| June 30, 2024 | $17.50M | +50.7% | +33.8% |
| March 31, 2024 | $13.08M | +21.9% | +12.8% |
| September 30, 2023 | $11.60M | +53.0% | -0.1% |
| June 30, 2023 | $11.61M | +73.2% | +8.2% |
- PROCEPT BioRobotics Corp showed an increase of +14.4% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, PROCEPT BioRobotics Corp’s r&d expense has grown by 338.0% (from $16.27 million to $71.28 million).
- The most recent figure is from PROCEPT BioRobotics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: